About Proveca
Proveca is a company based in Manchester (United Kingdom) founded in 2010. Proveca has raised $8.45 million across 2 funding rounds from investors including Kreos Capital, Albion Capital and Catapult Ventures. The company has 23 employees as of July 31, 2022. Proveca offers products and services including Paediatric Medicines. Proveca operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
- Headquarter Manchester, United Kingdom
- Employees 23 as on 31 Jul, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Proveca Limited
- Date of Incorporation 15 Jul, 2010
- Jurisdiction MANCHESTER, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.45 M (USD)
in 2 rounds
-
Latest Funding Round
$5.02 M (USD), Series A
Mar 29, 2017
-
Investors
Kreos Capital
& 2 more
-
Employee Count
23
as on Jul 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Proveca
Proveca offers a comprehensive portfolio of products and services, including Paediatric Medicines.
Develops treatments for children's neurological and cardiac conditions.
People of Proveca
Unlock access to complete
Funding Insights of Proveca
Proveca has successfully raised a total of $8.45M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.02 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Proveca
Proveca has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Kreos Capital, Albion Capital and Catapult Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment solutions are provided by Catapult Ventures for growth.
|
Locked | Locked | Locked | |
|
Venture debt is provided to growth-stage companies across multiple sectors.
|
Locked | Locked | Locked | |
|
Venture capital investments are managed by Albion Capital.
|
Locked | Locked | Locked |
Investor details for Proveca
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Proveca
Investment portfolio details for Proveca
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Proveca
Detailed financials for Proveca
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Proveca Comparisons
Peer comparison for Proveca
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Proveca
Proveca operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Drugs for CNS disorders are developed and advanced.
|
|
| Locked | Locked | Locked |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| Locked | Locked | Locked |
Therapies for neurological and neuropsychiatric diseases are developed.
|
Detailed competitors of Proveca
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Proveca
Complete news archive for Proveca
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proveca
Proveca was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Proveca is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Proveca is a funded company, having raised a total of $8.45M across 2 funding rounds to date.
As of Jul 31, 2022, the latest employee count at Proveca is 23.
Proveca was founded in 2010 in Manchester, United Kingdom, within the pharmaceutical sector focused on pediatric care. Medicines targeting chronic conditions such as Cerebral Palsy, Epilepsy, and Heart Failure in children are developed and commercialized. A facility for licensing off-patent medicines tailored for pediatric use is also operated, supporting therapy access in these areas.
Proveca's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Biohaven Pharmaceutical.
Proveca offers Paediatric Medicines.
Proveca has 3 investors. Key investors include Kreos Capital, Albion Capital, and Catapult Ventures.